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Abstract: 
Pathogenic microorganisms are persistently expressing resistance towards present generation antibiotics and are on the verge of 
joining the superbug family. Recent studies revealed that, notorious pathogens such as Salmonella typhi, Shigella dysenteriae and 
Vibrio cholerae have acquired multiple drug resistance and the treatment became a serious concern. This necessitates an alternative 
therapeutic solution. Present study investigates the utility of computer aided method to study the mechanism of receptor-ligand 
interactions and thereby inhibition of virulence factors (shiga toxin of Shigella dysenteriae, cholera toxin of Vibrio cholerae and 
hemolysin-E of Salmonella typhi) by novel phytoligands. The rational designs of improved therapeutics require the crystal structure 
for the drug targets. The structures of the virulent toxins were identified as probable drug targets. However, out of the three 
virulent factors, the structure for hemolysin-E is not yet available in its native form. Thus, we tried to model the structure by 
homology modeling using Modeller 9v9. After extensive literature survey, we selected 50 phytoligands based on their medicinal 
significance and drug likenesses. The receptor-ligands interactions between selected leads and toxins were studied by molecular 
docking using Auto Dock 4.0. We have identified two novel sesquiterpenes, Cadinane [(1S, 4S, 4aS, 6S, 8aS)- 4- Isopropyl- 1, 6-
dimethyldecahydronaphthalene] and Cedrol [(8α)-Cedran-8-ol] against Shiga (binding energy -5.56 kcal/mol) and cholera toxins 
(binding energy -5.33 kcal/mol) respectively which have good inhibitory properties. Similarly, a natural Xanthophyll, Violaxanthin 
[3S, 3'S, 5R, 5'R, 6S, 6'S)-5, 5', 6, 6'-Tetrahydro-5, 6:5', 6'-diepoxy-β, β-carotene-3, 3'-diol] was identified as novel therapeutic lead for 
hemolysin-E (binding energy of –5.99 kcal/mol). This data provide an insight for populating the pool of novel inhibitors against 
various drug targets of superbugs when all current generation drugs seem to have failed. 
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Background: 
The discovery and introduction of treatments by antibiotics 
after World War I resulted in a dramatic decrease in number of 
deaths due to bacterial infections. However, in the present era, 
these antibiotics have lost their status as the “miracle drug” and 
“treatment failure” is a new and often seen situation. The 
antibiotic resistance became sustainable in the environment as 
already resistant bacteria emerged as new dominant population 
and evolve as superbugs [1].  
 
The use, overuse and misuse of antibiotics in human and 
veterinary medicine are major promoters for the development 
and spread of multidrug resistant bacteria world-wide. 
However, large usage of antibiotics results in environmental 
releases. Even though, levels of antibiotics found in the 
environment are low, minimum inhibitory concentration for 
most bacteria, they may still result in an increased selection 
pressure at some sites [2]. In general practice, there are concerns BIOINFORMATION  open access 
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that some common infections are becoming increasingly 
difficult to treat and that illnesses due to antibiotic resistant 
bacteria may take longer to resolve. With the evolution of new 
antibiotic resistant microorganisms, there are reports indicating 
the end of era of antibiotics treatment and the need for new 
methodologies to target the pathogenic microorganisms [3].  
 
Cholera toxin is a protein complex secreted by the bacterium 
Vibrio cholerae which is responsible for the massive, watery 
diarrhea (cholera). It is a self-limiting illness. However, 
antibiotics are commonly administered as part of the treatment 
regimen. In recent days, the organism is becoming resistant for 
the multiple antibiotics [4]. Shiga toxin produced by Shigella 
dysenteriae  is responsible for shigellosis (bacillary dysentery). 
The disease has epidemic potential and threat in Central Africa, 
India and other developing countries in the world [5]. Many 
strains of S. dysenteriae were multidrug resistant, resistance to 
commonly used antimicrobials such as Ampicillin, Tetracycline, 
Cotrimoxazole, Amoxicillin, Nalidixic acid and 
Fluoroquinolones (such as Ciprofloxacin and Norfloxacin), 
which had unusually high minimum inhibitory concentrations 
[6]. Similarly, Hemolysin-E of Salmonella typhi act as virulent 
factors for enteric fever and food borne illness. In developed 
countries many strains were found to be zoonotic in origin and 
acquire their resistance in the food-animal host before onward 
transmission to humans through the food chain. The multi-drug 
resistant (MDR) strains of Salmonella typhi display resistance to 
most of the antimicrobials and exhibit decreased susceptibility 
to Ciprofloxacin and other current therapies [7]. 
 
The spread of the MDR superbugs urges the need for an 
alternative and promising therapy. Computer aided approach is 
a novel platform to screen and select better therapeutic 
substances from wide varieties of lead molecules. Many herbal 
derived compounds have significant inhibitory and 
antimicrobial properties against a broad range of pathogenic 
microorganisms  [8]. Our previous studies reported the 
applications of novel lead molecules against multidrug resistant 
Clostridium perfringens  [9] and Staphylococcus aureus  [10]. This 
study aims the selection of ligands from medicinal herbs and 
their utility as potential inhibitors against virulent toxins. There 
are many molecular studies indicated the scope of shiga toxin 
[11], cholera toxin [12] and hemolysin-E [13] of Shigella 
dysenteriae,  Vibrio cholerae and Salmonella typhi respectively as 
the probable drug targets for drug discovery. The 3D structures 
of these toxins are very essential for computer aided drug 
discovery and the structure of shiga toxin and cholerae toxin are 
available in their native form. Since there is no 3D crystal 
structure of hemolysin-E of Salmonella typhi, there is a need for a 
homology model. Furthermore, we have demonstrated the 
effective interactions between selected phytoligands and the 
drug targets by docking simulations. 
 
Methodology: 
Selection of the probable drug targets  
The cholera toxin of Vibrio cholerae,  shiga toxin of Shigella 
dysenteriae and hemolysin-E of Salmonella typhi were identified 
as probable drug targets based on their virulent function in the 
diseases. The 3D structures of proteins are the fundamental 
requirement for structure based drug designing. The crystal 
structures of shiga toxin, PDB: 1DM0 [14] and cholera toxin, 
PDB: 1XEZ [15] are available in their native form. But, the 3D 
structure of hemolysin-E is not available in native state. Hence, 
our preliminarily aim in this study was to focus on the 
hypothetical modeling of hemolysin-E by computer aided 
approach.  
 
Target retrieval and template selection 
The amino acid sequence of hemolysin-E, accession  number 
Q8Z727 [16], was retrieved from UniProt database. The FASTA 
sequence of the hemolysin-E was subjected to PSI – BLAST [17] 
analysis against PDB database for the selection of best 
homologous templates. The best template was selected based 
on percentage of identity, similarity, expectation value, bit 
scores and query coverage. A multiple sequence analysis was 
performed by T-COFFEE [18] and the phylogenetic 
characterization was carried out by NJ plot [19]. These steps 
ensured the accurate selection of the template for homology 
modeling.  
 
Homology modeling of hemolysin-E 
A 3D model of hemolysin-E was generated by Modeller 9v9 
[20]. It is a UNIX based programme based on satisfaction of 
spatial restraints derived from the alignment and probability 
density functions (PDFs). The chain-A of hemolysin from E. coli, 
PDB: 1QOY [21], was identified as the best template for 
comparative modeling. The template consists of 69% α-helices, 
14% coils, 12% of β-sheets and 5% of turns. The 3D structure 
was solved by X-ray diffraction studies and resolution was 
2.0Ao. The R-factor of the structure was 0.198 and R-free value 
was 0.252. The modeled protein was visualized using Chimera 
[22]. The model was energy minimized by CHARMM [23] and 
the stereo-chemistry was validated by Procheck [24]. The 
overall quality factor of non-bonded interactions between 
different atoms was calculated by ERRAT [25]. The backbone of 
the modeled protein was threaded against the template chain 
by DaliLite [26] and root mean square deviation (RMSD) 
between the model and the template was calculated. The 
hypothetical model was deposited to Protein model data base 
[27]. The modeled structure of hemolysin-E of Salmonella typhi, 
crystal structures of cholera toxin (1XEZ) from Vibrio cholerae 
and shiga toxin (1DM0) from Shigella dysenteriae were 
considered as the probable drug targets. 
 
Computer aided lead discovery 
Screening and selection of phytoligands 
Many antibiotics are available against the pathogens in 
contention of our study. Since the resistance towards these 
antibiotics is increasing, there is a need for the identification of 
natural substances which can act as potential drug candidates. 
Various phytoligands against the drug targets were identified 
by extensive literature studies. The 3D structures of all 
identified ligands were retrieved from PubChem [28] and 
ChemSpider [29] databases. The pharmacokinetic and druggish 
activities were studied by Lipinski’s Rule of Five [30]. The rule 
is one of the major landmarks for selecting the pharmacophoric 
pattern and biological behavior of the drug molecules. In our 
study, we selected 50 molecules were of herbal origin and that 
none of them showed any violation towards Lipinski’s rule.  
 
Docking studies and structure based drug design 
The selected phytoligands were docked against three toxins by 
Auto Dock 4.0 [31] using Lamarckian genetic algorithm. The 
catalytic and binding site of the target was identified and BIOINFORMATION  open access 
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selected by AutoGrid. The structure and chemical properties of 
the active site allows the recognition and binding of the ligand. 
The electrostatic interactions were evaluated by interpolating 
the values of the electrostatic potential and multiplying by the 
charge on the atom. Around 2,500,000 conformations were 
generated by ten iterations and the best conformations were 
screened in terms of lowest binding energy generated in the 
clustering histogram. The AutoDock program was executed to 
simulate the real time molecular interactions of the receptor and 
ligands. The function scoring, energy calculations and ranking 
of the best conformations were carried out as per energy 
minimization and stabilizing interactions. 
 
 
Figure 1: Three dimensional structure of hemolysin-E of Salmonella typhi generated by homology modeling; (A) The secondary 
structure of the protein displayed in Chimera shown that the toxin has seven alpha helical domains; (B) The Ramachandran plot of 
the model indicate 98.2% residues (A, B, L in the plot) are most favored region and 1.8 % (a, b, l, p regions) residues are additional 
allowed regions revealed the stupendous quality of the model; (C) The overall quality factor of non-bonded interactions between 
different atoms types estimated by ERRAT is 92.17 implies good validity of our structure. 
 
Disscussion: 
The shiga toxin of Shigella dysenteriae consists of two subunits. 
The subunit-A act as major virulent factor in most of the 
shigella infections. Crystal structure of the toxin (PDB: 1DM0) 
has 267 amino acids in which 34 % alpha helical structures (12 
helices constitutes 99 residues) and 23% beta sheet (15 strands; 
67 residues). This polypeptide is inhibiting protein synthesis 
through the catalytic inactivation of 60s ribosomal subunits. The 
subunit-B is 69 amino acids long (17% helical- 1 helices; 12 
residues; 36% beta sheet - 8 strands; 25 residues) and is 
responsible for the binding of the holotoxin to specific receptors 
on the target cell surface, such as globotriaosylceramide (Gb3) 
in human intestinal microvilli.  
 
The cholera toxin is a cytolysin which consists of 741 amino 
acids (PDB: 1XEZ) and has significant role in the pathogenesis 
of  Vibrio cholerae. The toxin has one polypetide chain, which 
constitutes 6% helices (10 helices; 50 residues) and 45 % beta 
sheets (56 strands; 327 residues.). The molecular weight of the 
toxin is 799.43 Kda and it act as potential virulent factor. During 
infection it causes cytolysis by forming heptameric pores in 
target host membranes. By considering the functional aspects of 
the toxins in pathogenesis, the crystal structures of toxin were 
used as probable drug targets. 
 
Salmonella typhi is another multiple drug resistance bacteria 
responsible for severe health hazards all over the world. Most 
strains of Salmonella secrete powerful toxin called hemolysin-E 
which act as major virulent factor. Hemolysin-E lyses 
erythrocytes and mammalian cells, forming transmembrane 
pores with a minimum internal diameter of 25 Ao. The three 
dimensional structure of toxin is not available in native form. 
Hence, we have modeled the structure of the toxin from its 
basic sequences. The sequence consists of 303 amino acids. The 
template selected for the modeling was chain-A of E. coli 
hemolysin with the length of 318 amino acids. The modeled 
protein has six alpha helical domains and it was visualized by 
Chimera (Figure 1A). The structure was energy minimized by 
CHARMM which yielded the energy value -2.14 kcal/mol from 
the previous energy value of -1.04 kcal/mol. The backbone 
structure of modeled protein is threaded with chain-A of 
template by DaliLite. The superimposition showed RMSD value 
of 0.2Ao with 298 aligned residue and 91% identity in their 
alignment. The modeled structure was steriochemically 
validated by Procheck. Ramachandran plot of the model 
indicated 98.2% of the residues in the allowed region, 1.2% of 
the residues in the additional allowed regions and no residues 
in the generously allowed and disallowed regions (Figure 1B). BIOINFORMATION  open access 
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The number of non-glycine and non-proline residues were 
identified as 282 and the number of glycine and proline 
residues present in the model was 15 and 4 respectively.  The 
overall quality factor of the hemolysin-E identified by ERRAT 
was 92.17 % (Figure 1C). The modeled structures further 
validated by PROVE indicated the Z-score mean as 0.96, Z-
score standard deviation as 29.87 and Z-score RMS as 29.873 
which indicate the reliable quality of the model. The model was 
deposited to Protein model data base which can be downloaded 
by the accession number PM0077415.  
 
Since, most strains of Vibrio cholerae,  Shigella dysentriae and 
Salmonella typhi showed multiple drug resistance, therapeutic 
significance of these drugs became limited. Hence, there is a 
need for a novel approach. The present approach mainly 
focused to inhibit the key virulent toxins of the pathogens. 
Many studies revealed the utilities of phytoligands as potential 
inhibitors against wide varieties of drug resistant bacteria [8]. 
Therefore, we also tried to screen 50 best phytoligands from 
various medicinal plant sources by extensive literature studies. 
The selected ligands were screened for better pharmacological 
features by Lipinski’s rule of five. All molecules showed very 
good physiochemical properties and drug likeness, enabling the 
molecule to exhibit good pharmacological properties.  
 
 
Figure 2: The docking simulations of novel phytoligands against probable drug targets of multidrug resistant pathogens. The 
ligands are displayed in the form of molecular surfaces and interacting residues and hydrogen bonds are shown in stick figures. 
(A) The interaction of shiga toxin (virulent factor of Shigella dysenteriae) and the best phytoligand, Cadinane is stabilized by weak 
interactions (residues Ile 24, Gly 25, Leu 39, Leu 38, Arg 21 Met 40 and Ile 41) with a minimum energy of -5.56 kcal/mol; (B) The 
docked conformation of Cholera toxin (virulent factor of Vibrio cholerae) and herbal ligand Cadinane is stabilized by a hydrogen 
bond with an energy minimum of -5.33 kcal/mol. The interacting residues are Lys 283, Val 285, Trp 318, Asp 624, Ser 623 and Tyr 
609; (C) Hemolysin-E (virulent factor of Salmonella typhi) interacted with Violaxanthin by a hydrogen bond and other interactions 
(Lys 38, Asp41, Lys 45, Phe 71, Glu85, Gln 81 and His 292) by the free energy minimum of –5.99 kcal/mol. Present docking studies 
revealed that herbal leads have good binding affinities against the drug targets and the data has crucial applications in further 
studies. 
 
The fundamental principle behind computer aided lead 
designing is the study of receptor ligand interactions. The 
inhibitory properties and best binding conformations of novel 
ligands can be studied by molecular docking. In the present 
study, docking was preceded by the addition of polar hydrogen 
charges to the target proteins. All phytoligands were docked 
against cholera toxin of Vibrio cholerae, shiga toxin of Shigella 
dysenteriae  and hemolysin-E of Salmonella typhi,  Table 1 (see 
supplementary material). The best binding poses and 
interactions were screened by minimum energy conformers. 
Moreover, other factors influencing the stability of the ligand–
receptor complexes, number of hydrogen bonds and Vander 
waals interactions, were also taken into consideration. Based on 
all these theoretical principles employed in docking studies, we 
identified the best phytolead against shiga toxin to be 
Cadinane, a medicinal compound of Gum myrhh (Commiphora 
myrrha), with minimum energy value of -5.56 kcal/mol and the 
interacting residues are Ile 24, Gly 25, Leu 38, Leu 39, Met 40 
and Arg 21, Ile 41 (Figure 2A).  The best inhibitor against 
cholera toxin identified from our study is Cedrol, a phytoligand 
present in Italian cypress (Cupressus sempervirens). The binding 
energy was found to be -5.33 kcal/mol and the interaction is 
stabilized by a hydrogen bond. The interacting residues are Lys 
283, Val 285, Trp 318, Asp 624, Ser 623 and Tyr 609 (Figure 2B).  
Similarly, the active compound found in varieties of squash, 
gourd, and pumpkin (Cucurbita pepo) known as Violaxanthin BIOINFORMATION  open access 
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was found to have significant inhibitory property against 
hemolysin-E. The binding energy was –5.99 kcal/mol and the 
interactions are stabilized by a hydrogen bond (Figure 2C). The 
amino acids present in the binding cavity of the toxin are Lys 
38, Asp 41, Lys 45, Phe 71, Glu 85, Gln 81 and His 292 Table 2 
(see supplementary material). 
 
Our studies concluded that, phytoligands such as Cadinane, 
Cedrol and Violaxanthin have significant inhibitory properties 
against  shiga, cholera and hemolysin-E toxins respectively. 
These compounds can be used to design novel therapy against 
multidrug resistant bacteria when all current generation 
antibiotics seem to have failed. From our study it is evident that 
present data find significant applications for further 
experimental studies. Moreover, the applied methods pave a 
new therapeutic insight against multiple drug resistant 
pathogens. 
 
Conclusion:  
The increase of multiple drug resistance has lead to the 
evolution of many superbugs including notorious pathogens 
such as Shigella dysenteriae, Vibrio cholerae and Salmonella typhi. 
Our present study concluded that computer aided approach 
may serve as an effective method to screen novel therapeutic 
leads when all current generation drugs seems to have failed. 
We could identify novel drug targets for multidrug resistant 
bacteria. In addition, we also studied the utility of structure 
based virtual screening to select new therapeutic substances. 
Phytoligands such as Cedrol, Cadinane and Violaxanthin can be 
used as potential inhibitors against virulent toxins of Shigella 
dysenteriae, Vibrio cholerae and Salmonella typhi respectively. 
However, experimental studies need to be performed to 
confirm the efficiency of the applied approach and present data 
finds applications for such studies. 
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Supplementary material:  
 
Table 1: Docking energies (kcal/mol) and drug likeness properties of selected herbal leads with shiga toxin, cholera toxin and hemolysin-E. Phytoligands such as 
Cadinane, Cedrol and Violaxanthin have significant inhibitory properties against shiga, cholera and hemolysin-E toxins respectively 
 
Table 2: The pharmacophoric properties and docking summary of best ligands against the drug targets of selected multiple drug resistant pathogens 
Ligand Toxin  Pathogen  Binding 
energy 
(Kcal/m
ol) 
Number of 
Hydrogen 
bonds 
Clustering 
RMSD 
Interacting residues 
of the toxin 
                     
                     Drug likeness properties of lead molecule 
Molecular 
weight 
(g/mol) 
Molecular 
Formula 
XLogP H-Bond 
donor 
H-Bond 
Acceptor 
Cadinane Shiga  toxin  Shigella 
dysenteriae 
-5.56  0  0.0  Arg 21, Ile 24, Gly 
25,Leu 39, Leu 38, 
Met 40, Ile 41 
208.38282 C15H28 6.2  0  0 
Cedrol Cholera  toxin  Vibrio 
choleare 
-5.33  1  0.0  Lys 283, Val 285, Trp 
318, Asp 624, Ser 
623,Tyr 609 
222.36634 C15H26O 3.9 1  1 
Violaxanthin Hemolysin  E  Salmonella 
typhi 
-5.99  1  0.0  Lys 38, Asp 41, Lys 
45, Phe 71, Glu 85, 
Gln 81, His 292, 
378.74718 C14H7ClN4O5S 3.8  1  6 
 
             ID  
ChemSpider / PubChem  
   Ligands  Cholera toxin 
(kcal/mol) 
Shiga toxin 
(kcal/mol) 
Hemolysin E 
(kcal/mol) 
Sources of Medicinal plant  Common name  Violation in 
Lipinski’s rule 
10659 Apiol  -3.42  -3.31  -4.01  Apium graveolens  Garden Celery   
552532 Asarone  -4.1  -3.87  -4.33  Coriandrum sativum  Coriander 0 
2265 Bergapten  -4.45  -4.16  -5.13  Citrus aurantium  Seville orange  0 
5026296 Borneol  -3.89  -3.9  -3.96  Cymbopogon nardus  Lemon grass  0 
34540 Cadinane  -4.81  -5.  56  -5.35  Commiphora myrrha  Gum myrhh  0 
600426 Caffeic  acid  -2.86  -3.78  -4.05  Melissa officinalis  Lemon balm  0 
6364 Camphene  -4.49  -4.23  -4.02  Angelica archangelica  Angelica 0 
24263 Carene  -4.46  -3.85  -4.05  Angelica archangelica  Angelica 0 
21105867 Carvacrol  -4.17  -3.37  -3.57  Origanum vulgare  Oregano plant  0 
7160 Carveol  -3.96  -3.89  -4.02  Eucalyptus polybractea  Eucalyptus 0 
7439 Carvone  -4.09  -3.74  -4.44  Eucalyptus polybractea  Eucalyptus 0 
4444848 Caryophyllene  -4.86  -4.98  -5  Cymbopogon martinii  Lemon grass  0 
65575 Cedrol  -5.33  -4.93  -5.1  Cupressus sempervirens  Italian cypress  0 
21105870 Cinnamyl  alcohol  -3.25  -2.96  -3.37  Cinnamomum species  Cinnamon 0 
553578 Citral  -3.27  -3.25  -3.6  Cymbopogon nardus  Lemon grass  0 
13850135 Citronellol  -3.26  -2.75  -3.24  Cymbopogon nardus  Lemon grass  0 
553148 Coumaric  Acid  -2.96  -3.59  -3.37  Leptospermum polygalifolium  Yellow tea tree  0 
23091 Cresol  -3.68  -3.5  -3.51  Commiphora myrrha  Gum myrhh  0 
83754 Cryptone  -4.18  -3.71  -4.17  Angelica archangelica  Angelica 0 
326 Cuminaldehyde  -3.67  -3.41  -3.89  Commiphora myrrha  Gum myrhh  0 
839564 Curcumin  -4.75  -3.65  -4.15  Curcuma longa  Turmeric 0 
7183 Cymene  -3.96  -3.76  -3.73  Angelica archangelica  Angelica 0 
4517049 Decenol  -2.55  -1.73  -2.49  Brassica oleracea  Cabbage 0 
8483 Estragol  -3.93  -3.52  -4.35  Artemisia dracunculus  Dragon's-wort   0 
13876103 Eugenol  -3.58  -3.31  -4.28  Commiphora myrrha  Gum myrhh  0 
13849989 Geraniol  -3.55  -3.14  -3.45  Cymbopogon nardus  Lemon grass  0 
1266019 Geranyl  Acetate  -3.29  -3.25  -3.51  Cymbopogon nardus  Lemon grass  0 
91904 Ledol  -4.92  -4.27  -4.87  Eucalyptus polybractea  Eucalyptus 0 
20939 Limonene  -4.08  -3.66  -5.28  Citrus reticulata var. madurensis  Variety of the Mandarin 
orange 0 
13849981 Linalool  -3.61  -3.94  -4.36  Cupressus sempervirens  Italian cypress  0 
4444655 Lutein  -2.67  -2.83  -5.29  Cucurbita pepo  Variety of Squash, gourd, 
and pumpkin  0 
6883 Methyl  Benzoate  -3.29  -3.49  -3.95  Antirrhinum majus  Snapdragon 0 
7731 Methylanisole  -3.65  -3.32  -3.6  Amorphophallus albispathus  Bagana(grown in Ethiopia)  0 
20473735 Methylisoeugenol  -4.1  -3.98  -4.4  Daucus carota  Carrot 0 
8143 Methylpyrrolidine  -3.23  -3.13  -2.94  Solanaceae families  Flowering plants  0 
28993 Myrcene  -3.23  -2.64  -2.85  Citrus paradisi  Grape fruit  0 
2341004 Neocnidilide  -4.43  -4.5  -4.97  Apium graveolens  Celery 0 
1266018 Neryl  Acetate  -3.07  -2.94  -3.95  Citrus aurantifolia  Citrus fruits  0 
913 Niacin    -3.68  -3.74  Vitis vinifera  Grape 0 
4444881 Ocimene  -3.38  -3.14  -3.41  Apium graveolens  Celery 0 
9811 Osthol -4.86  -3.81  -4.56  Citrus aurantium  Sweet orange  0 
10669 Phellandrene  -4.42  -3.93  -3.99  Eucalyptus polybractea  Eucalyptus 0 
6402 Pinene -4.35  -3.92  -4.04  Aniba rosaeodora  Magnoliid tree  0 
108603 Pinocarvone  -4.24  -4.39  -4.23  Eucalyptus polybractea  Eucalyptus 0 
17769 Sabenene  -4.23  -3.41  -3.44  Apium graveolens  Garden Celery  0 
151725 Senkyunolide  -4.42  -3.69  -4.65  Apium graveolens  Garden Celery  0 
10979 Terpinolene  -4.14  -4.06  -4.23  Citrus reticulata var. madurensis  Variety of the Mandarin 
orange 0 
229574 Thujone  -4.19  -4.14  -4.65  Citrus reticulata var. madurensis  Variety of the Mandarin 
orange 0 
83838 Verbenene  -4.53  -4.22  -3.99  Eucalyptus polybractea  Eucalyptus 0 
395237 Violaxanthin  -3.1  -2.65  -5.99  Cucurbita pepo  Varieties of squash, gourd, 
and pumpkin  0 